Earlier this month, changes to Texas’ limited medical access law took effect, permitting physicians to recommend low-THC, high-CBD formulations of cannabis to patients diagnosed with post-traumatic stress and cancer.
The new provision also increases the percent of THC available in the products from 0.5% to 1%.
Texas’ state legislature only meets every other year, so Texas will be off of the cannabis legislative map until at least 2023.
This article is reposted from https://www.thestreet.com/investing/cannabis-stock-roundup-state-legislature-edition